Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Deloitte
Merck
Healthtrust
Accenture
Chubb
UBS
US Department of Justice
US Army
Farmers Insurance

Generated: February 19, 2018

DrugPatentWatch Database Preview

Repaglinide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for repaglinide and what is the scope of repaglinide freedom to operate?

Repaglinide
is the generic ingredient in two branded drugs marketed by Gemini Labs Llc, Actavis Totowa, Aurobindo Pharma Ltd, Boscogen, Mylan Pharms Inc, Paddock Llc, Sandoz Inc, and Sun Pharm Inds Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for repaglinide. Seventeen suppliers are listed for this compound.
Pharmacology for repaglinide
Drug ClassGlinide
Mechanism of ActionPotassium Channel Antagonists

US Patents and Regulatory Information for repaglinide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd REPAGLINIDE repaglinide TABLET;ORAL 203820-002 Jan 22, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc REPAGLINIDE repaglinide TABLET;ORAL 078555-001 Nov 22, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd REPAGLINIDE repaglinide TABLET;ORAL 203820-003 Jan 22, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc REPAGLINIDE repaglinide TABLET;ORAL 078555-003 Jan 22, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-003 Apr 24, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-003 Dec 22, 1997 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Paddock Llc REPAGLINIDE repaglinide TABLET;ORAL 201189-001 Jul 17, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-001 Apr 24, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-001 Dec 22, 1997 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-002 Apr 24, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for repaglinide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-003 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-001 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-001 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-002 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-003 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-001 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-002 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-002 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-002 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-002 Dec 22, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Deloitte
Moodys
UBS
Citi
Fuji
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot